Free Trial Information
BioCentury | Aug 20, 2015
Distillery Techniques

Techniques: Co-crystal structures of small molecules with carbonic anhydrase IX (CAIX) mimetic and CAII for the design of CAIX-specific compounds

...Drug platforms CAIX CAII SignalChem Lifesciences Corp. SLC-0111 Bayer AG Seattle Genetics Inc. anti-CA9 ADC BAY...
Read More
BioCentury | Jan 5, 2015
Clinical News

SLC-0111: Phase Ia started

...SignalChem began an open-label, dose-escalation, Canadian Phase Ia trial to evaluate once-daily SLC-0111 in 28-day cycles...
...in 28-day cycles in up to 30 patients. SignalChem Lifesciences Corp. , Richmond, Beta.C. Product: SLC-0111...
Read More
Items per page:
1 - 2 of 2